Free Trial

Celcuity (CELC) Competitors

Celcuity logo
$70.15 +4.65 (+7.10%)
As of 03:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CELC vs. RDNT, BTSG, SHC, OPCH, WGS, PRVA, HTFL, VCYT, CON, and SGRY

Should you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry.

Celcuity vs. Its Competitors

RadNet (NASDAQ:RDNT) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

RadNet has higher revenue and earnings than Celcuity. RadNet is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$1.83B3.38$2.79M-$0.20-401.99
CelcuityN/AN/A-$111.78M-$3.45-20.33

RadNet currently has a consensus price target of $76.80, indicating a potential downside of 4.47%. Celcuity has a consensus price target of $65.50, indicating a potential downside of 6.63%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Celcuity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.13
Celcuity
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67

Celcuity has a net margin of 0.00% compared to RadNet's net margin of -0.78%. RadNet's return on equity of 2.41% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.78% 2.41% 0.82%
Celcuity N/A -150.07%-64.67%

In the previous week, Celcuity had 15 more articles in the media than RadNet. MarketBeat recorded 27 mentions for Celcuity and 12 mentions for RadNet. RadNet's average media sentiment score of 0.92 beat Celcuity's score of -0.11 indicating that RadNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
8 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celcuity
1 Very Positive mention(s)
7 Positive mention(s)
9 Neutral mention(s)
5 Negative mention(s)
3 Very Negative mention(s)
Neutral

RadNet has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500.

77.9% of RadNet shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 15.8% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

RadNet beats Celcuity on 11 of the 16 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELC vs. The Competition

MetricCelcuityMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.97B$3.41B$6.22B$10.49B
Dividend YieldN/A2.27%5.74%4.88%
P/E Ratio-20.3022.9428.6527.04
Price / SalesN/A425.29550.76162.85
Price / CashN/A46.4037.3861.65
Price / Book22.5610.4112.316.43
Net Income-$111.78M-$52.53M$3.33B$276.72M
7 Day Performance40.22%-1.69%-1.74%-2.95%
1 Month Performance33.64%9.45%4.72%-0.09%
1 Year Performance329.05%11.28%61.14%29.93%

Celcuity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELC
Celcuity
1.75 of 5 stars
$70.15
+7.1%
$65.50
-6.6%
+306.1%$2.97BN/A-20.3040News Coverage
Analyst Forecast
RDNT
RadNet
3.3853 of 5 stars
$71.72
+1.6%
$76.80
+7.1%
+19.7%$5.43B$1.83B-358.5811,021News Coverage
BTSG
BrightSpring Health Services
2.4341 of 5 stars
$29.48
+3.9%
$30.50
+3.5%
+100.4%$5.02B$11.27B95.1035,000News Coverage
Earnings Report
Analyst Forecast
SHC
Sotera Health
2.495 of 5 stars
$15.67
+2.1%
$17.20
+9.8%
+6.4%$4.36B$1.10B195.903,000News Coverage
OPCH
Option Care Health
4.7748 of 5 stars
$26.67
-0.1%
$35.11
+31.7%
-7.5%$4.33B$5.00B21.348,088Positive News
WGS
GeneDx
2.9003 of 5 stars
$120.87
-0.7%
$104.13
-13.9%
+109.3%$3.50B$305.45M2,417.401,200News Coverage
Upcoming Earnings
Analyst Forecast
PRVA
Privia Health Group
3.0373 of 5 stars
$24.14
+0.2%
$28.91
+19.8%
+46.8%$2.96B$1.74B219.471,140Positive News
HTFL
Heartflow
N/A$33.22
-0.7%
$36.60
+10.2%
N/A$2.79BN/A0.00699News Coverage
Positive News
VCYT
Veracyte
3.9824 of 5 stars
$34.09
-2.0%
$40.90
+20.0%
+9.0%$2.74B$445.76M103.31790Analyst Forecast
CON
Concentra Group Holdings Parent
2.5613 of 5 stars
$20.17
-0.7%
$27.75
+37.6%
-3.4%$2.60B$1.90B16.9511,250
SGRY
Surgery Partners
3.7636 of 5 stars
$19.79
+0.3%
$31.14
+57.4%
-33.9%$2.53B$3.11B-13.8415,000

Related Companies and Tools


This page (NASDAQ:CELC) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners